Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Emlak Konut Gayrimenkul Yatirim Ortakligi AS
IST:EKGYO.E
|
TR |
|
Limes Schlosskliniken AG
XETRA:LIK
|
DE |
|
Invesco Mortgage Capital Inc
NYSE:IVR
|
US |
|
S
|
Solwers Oyj
OMXH:SOLWERS
|
FI |
Dongkook Pharmaceutical Co Ltd
Interest Expense
Dongkook Pharmaceutical Co Ltd
Interest Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
|
Interest Expense
₩2.1B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
3%
|
CAGR 10-Years
25%
|
|
|
Yuhan Corp
KRX:000100
|
Interest Expense
₩15.4B
|
CAGR 3-Years
64%
|
CAGR 5-Years
42%
|
CAGR 10-Years
17%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Interest Expense
₩7.7B
|
CAGR 3-Years
27%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Interest Expense
₩980m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
9%
|
CAGR 10-Years
21%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dongkook Pharmaceutical Co Ltd
Glance View
DongKook Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2007-05-29. The firm develops and provides remedies for oral troubles, skin troubles and gynecology diseases, contrast mediums, anesthetics, anticancer medicines and circulatory system agents. The company also provides other pharmaceuticals, such as remedies for arthritis and pancreatitis, antiphlogistic, anodynes, antibiotics and vitamins, as well as raw materials for pharmaceuticals. In addition, it is engaged in the rental business. The firm distributes its products within domestic market and to overseas markets, such as Japan, Germany, India, Brazil and Mexico, among others.
See Also
What is Dongkook Pharmaceutical Co Ltd's Interest Expense?
Interest Expense
2.1B
KRW
Based on the financial report for Dec 31, 2025, Dongkook Pharmaceutical Co Ltd's Interest Expense amounts to 2.1B KRW.
What is Dongkook Pharmaceutical Co Ltd's Interest Expense growth rate?
Interest Expense CAGR 10Y
25%
Over the last year, the Interest Expense growth was -54%. The average annual Interest Expense growth rates for Dongkook Pharmaceutical Co Ltd have been -22% over the past three years , 3% over the past five years , and 25% over the past ten years .
